EC reveals plans for unitary SPC, compulsory licences

The European Commission will unveil plans to make supplementary protection certificates (SPC) more accessible and efficient for pharmaceutical companies to register and enforce by the end of March.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Europe

Chinese medtech company fined by UPC over injunction breaches

21 May 2026 The court has imposed a financial penalty after finding it continued promoting banned devices online despite an injunction covering five European countries.

Europe

Orrick lands five-member M&A team in Paris

18 May 2026 A high-profile Paris-based partner and four others join the firm, bringing experience across M&A, venture capital and life sciences-focused transactions.

Europe

IP in the deal room: The risks that bite before, during and after closing

7 May 2026 Experts from Johnson & Johnson and Novartis took the stage at INTA to share the pitfalls lurking inside mergers, acquisitions and spin-offs and what in-house counsel can do about them.

More features

Boehringer Ingelheim adds ex-Teva executive to patent team

Takeda’s China IP head: What companies are still getting wrong

AI, anxiety, and antibodies: The issues dominating life sciences

UPC judge: ‘Expectations of you as a woman are the challenge’

How should in-house teams adopt AI? ‘Carefully’, says secrets expert

Lupin scores another win in kidney drug dispute

Battle over inhaler shape ends badly for Boehringer

Chinese medtech company fined by UPC over injunction breaches

EC reveals plans for unitary SPC, compulsory licences

More on this story

Editor's picks

Editor's picks

More features